Trial Profile
Bone Mineral Density Effects of Zoledronate [zoledronic acid] in Postmenopausal Women With Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 05 Jul 2008 New trial record.